Immunome - Oncology Is Hot
January 10, 2024 at 17:44 PM EST
Immunome, an oncology biomedical company, has gained 27.48% since a buy signal on December 22.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|